Get Access!
AdisInsight APIs require API subscription as well as Springer Nature username and password.
Click the button below to login or register for Springer Nature account.
With your consent we’ll provide this information to your organization’s account administrator to aid in the renewal decision and we will send you important updates about AdisInsight.
Please refer to our
privacy policy
for information on how we protect your personal information.
Verification link has been sent to the e-mail address entered below. Click on that link to proceed.
Do you need help? Please contact one of our AdisInsight experts. We aim to get back to you with personalized answer within 24 hours.
Our team would reach out to you shortly in response for your query.
AdisInsight APIs require API subscription as well as Springer Nature username and password.
Click the button below to login or register for Springer Nature account.
A meticulously curated research collection of scholarly journals coupled with information about global drug development programs.
AdisInsight APIs are a collection of APIs that help you retrieve information from the AdisInsight database. Each of our APIs can be seen as building blocks for data integration, data analysis, and insight extraction.
Stay ahead in the competitive landscape with unparalleled access to the latest academic research and drug development landscape data with this API bundle consisiting of:
AdisInsight APIs A collection of APIs that help you retrieve information from the AdisInsight database. Each of our APIs can be seen as building blocks for data integration, data analysis, and insight extraction.
Springer Nature Full Text API (TDM) Springer Nature's Full Text API (TDM) offers access to a meticulously curated set of scholarly journals, and articles ensuring broad access to the latest research and insights. Tap into this rich repository to fuel competitive research in drug discovery, molecular biology, clinical pharmacology, and biotechnology:
To learn more, please visit: Springer Nature Data Solutions - Pharma API Bundle
1xx: Informational
2xx: Success
3xx: Redirection
4xx: Client Errors
5xx: Server Errors
When using the AdisInisght APIs you may occasionally encounter errors. Understanding these errors will help you troubleshoot and resolve issues quickly. This section provides an overview of the most common error codes, their causes, and how to fix them.
| Error Code | Status | Description | Possible Causes | How to Resolve |
|---|---|---|---|---|
| 400 | Bad Request | The request was invalid or malformed. | Incorrect query parameters or missing fields. | Double-check the request format and ensure all required parameters are included. |
| 401 | Unauthorized | Authentication failed due to missing or invalid API key. | API key is missing, expired, or invalid. | Ensure that a valid API key is included in the request headers or URL. |
| 403 | Forbidden | You do not have the necessary permissions to access this resource. | Attempting to access restricted content or using an incorrect API key. | Verify that your API key has the appropriate access permissions for the requested resource. |
| 404 | Not Found | The requested resource could not be found. | Invalid endpoint or resource identifier (e.g., DOI). | Ensure that the resource you’re trying to access exists and that the endpoint URL is correct. |
| 429 | Too Many Requests | You have exceeded the allowed rate limits for your API plan. | Making too many API calls in a short period. | Slow down the rate of requests, or upgrade to the Premium Plan for higher limits. |
| 500 | Internal Server Error | The server encountered an unexpected condition that prevented it from fulfilling the request. | Temporary issue on the server side. | Try the request again after a few minutes. If the problem persists, contact support. |
| 503 | Service Unavailable | The server is temporarily unavailable, usually due to maintenance or overload. | API service is down or overloaded. | Wait a few minutes and try again. Check the status page for any ongoing issues. |
Join us for an insightful discussion lead by experts from AdisInsight who will explore the biggest M&A deals of 2025 and their strategic impact, the evolving role of licensing agreements and R&D collaborations, and key trends driving pharma's deal-making landscape and what's next.
Register Here